Étude coût-conséquences sur la capsaïcine en patch cutané dans un CHU français
Tài liệu tham khảo
Attal, 2010, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur J Neurol Off J Eur Fed Neurol Soc, 17, 1113-e88
Bouhassira, 2008, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, 136, 380, 10.1016/j.pain.2007.08.013
Saarto, 2007, Antidepressants for neuropathic pain, Cochrane Database Syst Rev, 17
Dworkin, 2007, Pharmacologic management of neuropathic pain: evidence-based recommendations, Pain, 132, 237, 10.1016/j.pain.2007.08.033
Wiffen, 2005, Anticonvulsant drugs for acute and chronic pain, Cochrane Database Syst Rev, 20
Wiffen, 2011, Carbamazepine for acute and chronic pain in adults, Cochrane Database Syst Rev, 19
HAS, 2010
Conseil de l’hospitalisation, 2010
Farrar, 2000, Defining the clinically important difference in pain outcome measures, Pain, 88, 287, 10.1016/S0304-3959(00)00339-0
Comité Économique des Produits de Santé (CEPS), 2013, Prix des médicaments [Internet]
HAS, 2007, Prise en charge diagnostique des neuropathies périphériques (polyneuropathies et monopathies multiples)
Fabre, 2012
Maihofner, 2013, Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study, Curr Med Res Opin, 29, 673, 10.1185/03007995.2013.792246
Backonja, 2008, NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, Lancet Neurol, 7, 1106, 10.1016/S1474-4422(08)70228-X
Beauvieux, 2014, Registre observationnel de l’efficacité et de la tolérance de la capsaïcine 8 % (Qutenza®) dans les douleurs neuropathiques périphériques localisées pharmacorésistantes, Douleur Analg, 27, 110, 10.1007/s11724-014-0367-y
Société Française d’Étude et Traitement de la Douleur, 2010, Les douleurs neuropathiques chroniques : diagnostic, évaluation, traitement en médecine ambulatoire. Recommandation pour la pratique clinique de la Société Française d’Étude et de Traitement de la Douleur, Douleur Analg, 23, 51, 10.1007/s11724-010-0180-1
EU Clinical Trials Register, 2011
Guignard, 2006, Kétamine : quelle place, quelles indications, quelles limites ?, 629
Armoiry, 2014, Economic impact of ephedrine prefilled syringes in anaesthesiology, Ann Fr Anesth Reanim, 33, 47, 10.1016/j.annfar.2013.11.015
EU Clinical Trials Register, 2012